Sarah Kim, MD, FACOG
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
Conditions I Treat
- Ovarian cancers and conditions
- Uterine cancers and conditions
- Cervical cancers and conditions
My Specialties
- Cytoreductive (debulking) surgery
- Minimally invasive surgery
- Robotic surgery
Get to Know Me
As a gynecologic surgeon, I specialize in the care of women with ovarian, uterine (endometrial), cervical, vulvar, and vaginal cancer. I have extensive training in minimally invasive surgical approaches, including robotic-assisted procedures, that can help patients recover faster with shorter hospital stays and less pain. I also am experienced in performing extensive open surgeries for patients with advanced and recurrent cancer.
At Memorial Sloan Kettering Cancer Center, I work closely with a multidisciplinary team of specialists, including radiation oncologists, medical oncologists, and pathologists, to create an individualized plan for each patient. In my practice, I see many women who are at a high risk for gynecologic cancer and would like to pursue risk-reducing surgery. Whether a patient is at risk for developing gynecologic cancer or has received a diagnosis, I am committed to providing compassionate care as we navigate diagnosis, treatment, and ultimately, survivorship.
When I am not in the clinic or the operating room, I am conducting research on biomarkers for ovarian and cervical cancer, the genetic drivers of rare gynecologic cancers, and novel therapeutic targets. Our laboratory uses cutting-edge tools to study the mechanisms of ovarian, cervical, and endometrial cancer development. This information helps us to better understand how and why some cancers become resistant to treatment and discover new therapeutic targets.
I have received numerous awards for clinical excellence, surgical expertise, education, and research, including the William J. von Liebig and Sarnoff Research Foundation Fellowships, multiple teaching awards, the Robert F. Porges Honor Resident Award, and the Michael E. Burt Memorial Award for Clinical Excellence.
I am a member of the Society of Gynecologic Oncology (SGO), the American Society of Clinical Oncology (ASCO), the American College of Obstetricians and Gynecologists (ACOG), the Bellevue Obstetrics and Gynecology Society (BOGS), the American Association of Gynecologic Laparoscopists (AAGL), and the American College of Surgeons (ACS).
I'm a gynecologic (GY-neh-kuh-LAH-jik) surgeon, which is a doctor with special training in surgery on the female reproductive system. This includes the cervix, endometrium, fallopian tubes, ovaries, uterus, vagina, and vulva.
- Assistant Attending Surgeon
Conditions I Treat
- Ovarian cancers and conditions
- Uterine cancers and conditions
- Cervical cancers and conditions
- Vulvar cancers and conditions
- Vaginal cancers and conditions
- Gestational trophoblastic disease (GTD)
My Specialties
- Cytoreductive (debulking) surgery
- Minimally invasive surgery
- Robotic surgery
- Fertility-sparing surgery
- Cancer prevention in high-risk patients
Education
- MD, Drexel University College of Medicine
Residencies
- Obstetrics and Gynecology, New York University School of Medicine
Fellowships
- Gynecologic Oncology, Memorial Sloan Kettering Cancer Center
Board Certifications
- Obstetrics and Gynecology
Awards and Honors
- Michael E. Burt MD, PhD Award for Superior Clinical & Operative Skills, Department of Surgery, Memorial Sloan Kettering Cancer Center (2022)
- The Foundation for Women’s Cancer Grant (2020)
- Robert F. Porges Honor Resident Award, Department of Obstetrics and Gynecology, New York University School of Medicine (2018)
- Excellence in Teaching Award, Department of Obstetrics and Gynecology, New York University School of Medicine (2018)
- The Department Award for Leadership in the field of Obstetrics & Gynecology (2014)
- The Diana J. Egan Award for Excellence in Obstetrics & Gynecology (2014)
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, EPO PPO, POS, Transplant
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
POS, EPO, HMO
In Network Coverage Type
State Government
In Network Coverage Type
State Government
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
State Government
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO EPO
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
TBD
In Network Coverage Type
PPO, POS, EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
HMO
City Employee Health Plans (Gold and Gold Care)
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO/OAP
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO/EPO
In Network Coverage Type
PPO, EPO
In Network Coverage Type
State Government
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO, POS
In Network Coverage Type
PPO, POS, HMO
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Kim SH, Basili T, Dopeso H, Da Cruz Paula A, Bi R, Issa Bhaloo S, Pareja F, Li Q, da Silva EM, Zhu Y, Hoang T, Selenica P, Murali R, Chan E, Wu M, Derakhshan F, Maroldi A, Hanlon E, Ferreira CG, Lapa E Silva JR, Abu-Rustum NR, Zamarin D, Chandarlapaty S, Matrai C, Yoon JY, Reis-Filho JS, Park KJ, Weigelt B. Recurrent WWTR1 S89W mutations and Hippo pathway deregulation in clear cell carcinomas of the cervix. J Pathol. 2022 Aug;257(5):635-649. doi: 10.1002/path.5910. Epub 2022 May 20. PMID: 35411948.
Kim SH, Da Cruz Paula A, Basili T, Dopeso H, Bi R, Pareja F, da Silva EM, Gularte-Mérida R, Sun Z, Fujisawa S, Smith CG, Ferrando L, Martins Sebastião AP, Bykov Y, Li A, Silveira C, Ashley CW, Stylianou A, Selenica P, Samore WR, Jungbluth AA, Zamarin D, Abu-Rustum NR, Helin K, Soslow RA, Reis-Filho JS, Oliva E, Weigelt B. Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovary. Nat Commun. 2020 Jan 2;11(1):44. doi: 10.1038/s41467-019-13806-x. PMID: 31896750; PMCID: PMC6940380.
Da Cruz Paula A, da Silva EM, Segura SE, Pareja F, Bi R, Selenica P, Kim SH, Ferrando L, Vahdatinia M, Soslow RA, Vidal A, Gatius S, Przybycin CG, Abu-Rustum NR, Matias-Guiu X, Rubin BP, Reis-Filho JS, DeLair DF, Weigelt B. Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary. Mod Pathol. 2020 Aug;33(8):1606-1617. doi: 10.1038/s41379-020-0514-3. Epub 2020 Mar 12. PMID: 32203090; PMCID: PMC7390666.
Visit PubMed for a full listing of Dr. Kim’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.
MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.
Sarah Kim discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.